Wei Xie , Shanzhi Tan , Xiyun Ren , Jinling Yu , Chen Yang , Hongquan Xie , Zihui Ma , Ying Liu , Shucai Yang
{"title":"Tumor-targeted astaxanthin nanoparticles for therapeutic application in vitro","authors":"Wei Xie , Shanzhi Tan , Xiyun Ren , Jinling Yu , Chen Yang , Hongquan Xie , Zihui Ma , Ying Liu , Shucai Yang","doi":"10.1016/j.colcom.2023.100721","DOIUrl":null,"url":null,"abstract":"<div><p>In recent years, with the development of molecular biology, the exploration and development of targeted drugs for cancer has gradually attracted widespread attention. Here, tumor-targeted astaxanthin nanoparticle, cRGD-PEG2000-DSPE encapsulated astaxanthin (cRGD@AST) was designed and applied for tumor therapy. Firstly, cRGD@AST can improve the water solubility of astaxanthin. Secondly, cRGD@AST can achieve tumor-targeted ability after cRGD modification and can be highly absorbed by HepG2 cells. Finally, cRGD@AST can scavenge excess ROS in tumor cells, restore the redox balance in cells, and inhibit tumor cell proliferation. It provides theoretical basis and experimental basis for the development and utilization of natural product antioxidants for cancer prevention and treatment.</p></div>","PeriodicalId":10483,"journal":{"name":"Colloid and Interface Science Communications","volume":"55 ","pages":"Article 100721"},"PeriodicalIF":4.7000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloid and Interface Science Communications","FirstCategoryId":"88","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2215038223000286","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 1
Abstract
In recent years, with the development of molecular biology, the exploration and development of targeted drugs for cancer has gradually attracted widespread attention. Here, tumor-targeted astaxanthin nanoparticle, cRGD-PEG2000-DSPE encapsulated astaxanthin (cRGD@AST) was designed and applied for tumor therapy. Firstly, cRGD@AST can improve the water solubility of astaxanthin. Secondly, cRGD@AST can achieve tumor-targeted ability after cRGD modification and can be highly absorbed by HepG2 cells. Finally, cRGD@AST can scavenge excess ROS in tumor cells, restore the redox balance in cells, and inhibit tumor cell proliferation. It provides theoretical basis and experimental basis for the development and utilization of natural product antioxidants for cancer prevention and treatment.
期刊介绍：
Colloid and Interface Science Communications provides a forum for the highest visibility and rapid publication of short initial reports on new fundamental concepts, research findings, and topical applications at the forefront of the increasingly interdisciplinary area of colloid and interface science.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
